Profound Medical Corp. (NASDAQ:PROF; TSX:PRN) (“Profound” or the “Company”), a commercial-stage medical device company that develops and markets AI-powered, MRI-guided, incision-free therapies for the ...
Myths debunked: no impact on ejaculation, erections, or risks like cardiovascular disease. If you’re considering getting a ...
World’s first robotic Prostatic Artery Embolization (PAE) for Benign Prostatic Hyperplasia (BPH) and robotic Y-90 radioembolization mapping for ...
Francis Medical, Inc., a privately held medical device company, announced today the successful completion of the first commercial (non-clinical study) procedure on the East Coast using the Vanquish(R) ...
Men with prostate cancer have a major decision to make: whether to get a lifesaving surgery. Radical prostatectomy, the ...
When Mike Wooldridge was diagnosed with prostate cancer, he and his wife, Ann, were apprehensive about the treatments and ...
The American Urological Association guideline emphasizes that vasectomy is a safe, permanent contraceptive option with no ...
A non-ablative treatment for benign prostatic hyperplasia (BPH)/lower urinary tract symptoms (LUTS) achieved durable ...
Wrapping dehydrated human amniotic membrane around nerve and anastomotic tissue during robotic prostatectomy was associated ...
Men with a shorter membranous urethra appear more likely to experience urinary incontinence after laser enucleation for ...
– First multicenter, randomized controlled trial directly comparing a new technology to robotic RP for men with localized prostate cancer to successfully recruit to target enrollment – – TULSA ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results